Liz Tate: First Percutaneous LAAO Procedure Performed at The Park Hospital for Stroke Prevention
Liz Tate, Clinical Lead – Cath Lab at The Park Hospital, shared a post on LinkedIn:
“Proud to share a major milestone: leading the team at The Park Hospital and completing our first-ever percutaneous left atrial appendage occlusion (LAAO)!
This innovative procedure offers a vital, stroke-reducing alternative for patients with atrial fibrillation who cannot tolerate long-term anticoagulation therapy.
A huge thank you to Ashan Gunarathne for his exceptional leadership and guidance in the cath lab, and a special thank you to Nisha Patel and the Boston Scientific team for their brilliant support and collaboration in making this milestone possible.
Also for sharing your expertise and providing comprehensive training to the team.
Milestones like this happen because of great teamwork, dedication, and a shared drive to push patient care forward.
Looking forward to what’s next!”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 08:26Robert Sidonio: WFH Webinar to Address Key Challenges in Rare Bleeding Disorders Care
-
Nov 21, 2026, 08:21Jenni Majumdar: What Changing Blood Transfusion Guidelines Mean for Patients and Surgical Teams
-
Nov 21, 2026, 08:17Doaa El Demerdash: The Bridge Meeting Fosters International Dialogue on Hemophilia Care
-
Nov 21, 2026, 08:16Emily Branchard: Uncoupling Anticancer and Antiplatelet Effects of Dipyridamole Analogs
-
Nov 21, 2026, 08:10Rory R Koenen: Xin Xin Earns PhD for Research on Extracellular Vesicles and Vascular Inflammation
-
Nov 21, 2026, 08:06Andrew Hill: How Do You Build Loyalty when Financial Incentives Are off the Table?
-
Nov 21, 2026, 08:00Kevin Dean: How Leptin Receptor Positive Stromal Cells Regulate Platelet Production
-
Nov 21, 2026, 07:59William Aird: The Blood Project Makes Its First Appearance at ASH 2026
-
Nov 21, 2026, 07:52Michael Holmes: Why Matched Platelet Donations Matter for Refractory Patients